Archived This bill is from the 117th Congress (2021–2022) and is no longer under active consideration.
A bill to provide for the use of emergency use authorization data and real world evidence gathered during an emergency to support premarket applications for drugs, biological products, and devices, and for other purposes.
Senate: Referred